ClinTec International has opened two new offices in Spain, alongside the appointment of Carlos Palacios as the company’s new regional manager for Spain and Portugal.

ClinTec is a full-service, global contract research organization (CRO) and functional service provider (FSP). Headquartered in the UK, ClinTec provides customized clinical research solutions to progress drug development in areas such as immuno-oncology and rare diseases.

ClinTec is adding capabilities to Spain and Portugal as a key target market in Europe, moving to a larger office in Barcelona, opening a new office in Madrid and strengthening the management team with the appointment of Carlos Palacios as regional manager.

Mr. Palacios joins ClinTec from Merck Serono where he had oversight of global trials across Spain, Portugal, Israel and the Netherlands. He has over 16 years of experience in the clinical research industry at local and global levels.

The opening of larger premises in Barcelona and a new hub in Madrid cement the capability for expanding the local clinical trial portfolio, while accommodating larger functional outsourcing engagements in Spain.

“We have now entered a new phase of development and are on track to scale the organization considerably in the next 12 months as we enter our 20th year of growth,” said Rabinder Buttar, chief executive officer and founder, ClinTec International. “The creation of the new regional management post and the opening of the two new offices in Madrid and Barcelona signal that ClinTec is developing and expanding in line with our current clients’ needs and that as a company we are ready to take on new business of all sizes. I am delighted Carlos has joined our team at ClinTec, as we continue to expand our business in the Spanish and Portugese region.”

ClinTec’s new locations can be found at Paseo Castellana, Madrid and Gran Vía Carles III, Barcelona, 84 – Planta.